Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) CEO Seth Lederman presents to investors at Proactive's One2One Virtual Event.
Tonix is a New York-based, clinical-stage biopharmaceutical company focused on discovering and developing small molecules and biologics to treat psychiatric, pain and addiction conditions.
Price: 0.91 USD
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of Tonix Pharmaceuticals named herein, including the promotion by the Company of Tonix Pharmaceuticals in any Content on the Site, the Company...
FOR OUR FULL DISCLAIMER CLICK HERE
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) CEO Dr Seth Lederman tells Proactive the clinical-stage biopharmaceutical company has signed a second research collaboration agreement with Massachusetts General Hospital. Dr Lederman says while the first collaboration is centered on heart...
Health
Industry & services
Retail & consumer
Finance
Mining
Prev article
